Forian Inc (FORA)

Forian Inc. announced its Third Quarter 2025 Financial Results on November 14, 2025, reporting a 66% year-over-year revenue increase to $7.76 million. In November 2024, Forian acquired Kyber Data Science LLC from TD Cowen, expanding its data analytics capabilities and entering the financial services industry. On December 16, 2024, Forian partnered with Databricks to expand access to advanced healthcare analytics. In December 2025, Forian Inc. detailed its plan to redomicile from Delaware to Maryland, with holders backing the move in January 2026. On January 14, 2026, Forian's CFO had 18,077 shares withheld for taxes owed. On November 12, 2025, the CFO reported tax-withheld RSU shares, and on November 4, 2025, Forian awarded 150,000 RSUs at $2.24 with a 4-year vest. As of February 6, 2026, Forian's stock price was $2.09, with a 3.49% change over the past year and a 52-week range between $1.64 and $4.03.

Forian Inc. typically experiences seasonal trends in its results, with the fourth quarter usually being its strongest.

Forian, Inc. is a healthcare technology company specializing in data science-driven information and analytics solutions, operating primarily in the Health Information Services industry. The company's core business revolves around its "Data Factory," which ingests, processes, and delivers real-world data to generate connected, quality insights. Forian's solutions aim to optimize and measure operational, clinical, and financial performance for its clients. Major products and services include data and analytics solutions, HEOR/RWE, the Kyber Data Science Suite, clinical laboratory services, HIE and interoperability solutions, telehealth and remote patient monitoring, an EHR system, medical billing services and revenue cycle management, and consulting and professional services. Forian divested BioTrack to refocus solely on core healthcare and life sciences activities.

Forian Inc. is headquartered in Newtown, Pennsylvania, and operates across the U.S. It had a notable presence on the East Coast for its cannabis-related solutions and its government-side business is active in approximately 13 states.

Forian emphasizes its commitment to a "Differentiated Standard of Excellence in Life Sciences Data Products and Services" and highlights its platform as "among the industry's largest integrated SOC-2 / HIPAA-compliant healthcare data and analytics platforms," suggesting a focus on data security and regulatory compliance. The acquisition of Kyber Data Science and expansion into financial services analytics, along with partnerships like the one with Databricks, indicate strategic moves to enhance its offerings and market position.

Approximately 12.94% of Forian's stock is held by institutional shareholders, including Oracle Investment Management Inc., Staley Capital Advisers Inc., and Vanguard Group Inc. Insiders hold a substantial 61.28% of the company's shares, with key individual insider shareholders including Adam H. Dublin, Wygod Family Dynasty Trust Max, Edward Francis Spaniel Jr., Martin J. Wygod, and Max C. Wygod. Retail investors account for approximately 25.79% of the ownership.